|
|
||
May 2009
Special
Edition |
|
|
In This Issue
· Yesteryear’s News Sold as Today’s Miracle Science Advisory Board
Roberto Jorge Fernandez
Viña, MD Honorary Professor University Maimonides Argentina Honorary Professor University of Beijing, China Shimon Slavin, MD Professor of Medicine Medical & Scientific
Director Carlos Lima, MD Zannos G. Grekos, MD Kitipan V. Arom, MD,
PhD, FACS, FACC, FACCP, FRCST Don Margolis www.repairstemcells.com |
Only when one eye is blind behind rose colored glasses, can yesteryear’s news be sold as today’s miracle.The North
American and European print media are still exercising the attributes of
denial, ignorance and selective consideration when researching and writing
the headlines and stories about stem cell treatment victories. Let me sum up the media flurry of the past
5 years when it comes to stem cell treatment articles.
Let’s
review the facts: ·
To
date, ESC HAVE NOT
successfully completed one real clinical trial or even one serious test on a
group of animals, for ANY disease EVER! ·
To
date, ASC HAVE treated
thousands of people around the world, suffering from 100+ so-called incurable
diseases…and treated them SUCCESSFULLY! For five
years, I read about breakthroughs, miracles and potentials happening in the
US with adult stem cells. I should be
glad. But how could I be when the
overriding rule in American newspapers is never to allow the word “adult” to
precede the words “stem cells” in such articles, thereby convincing the
kept-ignorant public that such victories were from ESC research. The print
media constantly extol the virtues of ESC research producing cures. Thankfully,
they are beginning to wise up and listen to some of the greatest ESC
scientists in the world who have clearly stated that there will be NO
treatments from ESC for 10, 20, even 50 years. Link: http://repairstemcell.wordpress.com/screw-the-embryos-they%e2%80%99re-irrelevant/ Now they
are starting to sneak in the correct type of stem cells in their “victory,”
“breakthrough” and “miracle” articles.
The only problem is, they are missing the dates…by years. Virtually every one of the advances
currently promoted in major print media has already occurred in multiple
countries outside the US…years ago. The
latest example is from an article entitled, “Healing the Heart with Bone-Marrow Cells.” The subtitle is, “A new treatment may help angina sufferers who are resistant to
surgery and medication.” This is a
NEW treatment? Let’s see… |
|
|
2001 – Human studies and trials using
adult stem cells to re-grow muscle tissue, including cardiac muscle tissue, were
begun in many countries around the world. 2002 – In Rotterdam, a patient gets
stem cells injected through a catheter into the wall of his heart. Results are
improved ejection fractions, reduced diameters, thicker muscle tissue. 2003 – The American Heart Association
accepted and publicized the greatest heart clinical trial in history—out of
Brazil. Dying transplant candidates
were brought back to near-normal lives---and American medical “science”
ignored it, as they were instructed by their Lords and Masters. 2004 – The first-ever commercial stem
cell treatment center in the world is Healing
the Heart with Autologous (from the patient’s body) Stem Cells and re-growing
human cardiac muscle tissue in hundreds of patients. Their procedures are based on a clinical
trial that proved that their adult stem
cells helped angina sufferers who are resistant to surgery and medication. Sound familiar? But their 2005-06 scientific
paper was accepted by the American Heart Association in the middle of the
five year period 2004-2008 when Adult Stem Cell victories were (and still
are) all but banned from American “Medical” Journals. This means that today, five years too late,
it is NEWS in the Developed World! 2009 – Present day. There are currently dozens of stem cell
treatment centers around the world who are Healing the Heart with Bone-Marrow Cells and using adult stem
cells to treat human patients and re-grow both cardiac and skeletal muscle
tissue and more. Conclusion: This “breakthrough”
is not NEW. One must blatantly ignore/disregard
almost a decade of medical history and thousands of successful treatments
around the world to call it new. One must
completely rewrite history, turning a blind eye to the past and then falsely
glamorize this accomplishment as “news.”
In other words… “Only when one eye is blind behind
rose colored glasses, can yesterday’s news become today’s miracle.” It is
time to put a stop to these purposely deceitful articles about stem cell
facts, history and available treatments.
North America is now, and will be, the Bangladesh of stem cell science
as long as the huge medical businesses which control 80% of Congress, 90% of
scientists, and 100% of the White House and the FDA are in charge, which
means at least for YOUR lifetime. For 12
other articles about revolutionary cardiac advances that are 4-6 years late: Dogs Yes, People No"There are other possibilities out
there besides pills or a doctor's knife," This is a story about a dog named Rusty and
her owner, whom we’ll call Mrs. Spring. One day
last fall, Rusty started limping — which was odd because the German shepherd
seemed fit and was not yet four years old. "She wasn't recovering as
quickly as normal from a trek in the park,” remarked Spring. In fact,
Rusty had hip dysplasia. The cure — a
complete hip replacement — would keep Rusty in recovery for up to six months.
Rusty's regular veterinarian sent Mrs. Spring to see another local vet who
was trained in acupuncture, to treat Rusty's pain. But that lady had a better
idea. She offered a state-of-the-art stem-cell transplant, a therapy not yet
available to humans that would potentially help Rusty's hip repair itself. The
treatment took just two days. She injected them into Rusty's failing hip,
where they adapted and developed into the healthy cartilage and tendon cells
the animal needed. Within 36 hours, "Rusty was moving well, and you
could see an ease in her gait," says Mrs. Spring. For now, Rusty is
fully cured and back to running and swimming and playing with her friends. "There
are other possibilities out there besides pills or a doctor's knife,"
says the veterinary oncologist who incorporated alternative treatments into
her practice four years ago. Most
progressive veterinary therapies are inspired by human health care. Burton
Miller, who runs the Animal Wellness Center in Huntington Station, N.Y.,
became a practitioner of Eastern medicine for animals after suffering a
skiing accident in 1996. He began reading up on alternative therapies for his
injury and decided to apply the same kind of medicine to his animal patients.
"I announced to my [clients] that everything I had ever told them was
wrong," he says. Those pet owners promptly abandoned him, but today he
has a thriving practice in which acupuncture and homeopathic medicines are
the most common courses of treatment. (A veterinary visit including
acupuncture with Miller costs $65 — about what a human acupuncturist in
Manhattan charges.) Unlike
these older, more popular therapies, some vets now offer better medicine to
animals than are allowed and available to their owners, even though they do
not use controversial embryonic stem cells!
The fatty-tissue stem-cell transplant has not yet secured FDA approval
for use in humans, but pets in droves are reaping the benefits. This movement
to beneficial treatment without pills and scalpels is led by a company called
Vet-Stem. Since it began offering its online certification course in January,
more than 1,000 vets have signed up to take it, many at the urging of their
patients' owners. The FDA has so far approved the treatment for animals'
orthopedic problems in tendons and ligaments, and for bone fractures and
arthritis. Vet-Stem says that some of its patients begin to show increased
mobility and decreased sensitivity at the location of the injury the same day
and most improve within a week. About 20% see no progress at all. Vet-Stem has not received reports of any
negative effects and this is not surprising, as they saw no negative effects
in their clinical trials. A cycle of
stem-cell treatment generally costs $2,000 to $4,000, including the
extraction, surgeries and follow-up. Canine hip-replacement surgeries,
however, can be about four times as expensive. Robert Harman, Vet-Stem's
founder, says that he initially thought wealthy horse owners would be his
primary clientele. "Turns out there's not quite the same emotional
attachment to horses as in the small-animal world," Harman says.
"It used to be if your dog got sick, you just got a new dog. Now people
want the best care." At the
start of the year, Vet-Stem's patient pool was 90% horses and 10% dogs. By
the end of 2008, Harman estimates those numbers will shift to 60% dogs, 10%
cats and 30% horses — no doubt aided by word-of-mouth praise from pet owners
like Mrs. Spring. "It's comforting for me to know I've done what I can
to alleviate Rusty's pain," Mrs. Spring says. "She loves to play so
much that fixing her hip really improved both our qualities of life." For eleven other dog, horse and mountain
lion stem cell treatment stories, including: “Will
Rover Outlive Grandma?” “Horsing
Around With Stem Cells” “Rover’s
Do Over” http://repairstemcell.wordpress.com/2009/03/07/lions-and-puppys-and-horseys-oh-my/ “To summarize,” said Mr. Margolis, “these five men have improved the lives of more ‘untreatable’ patients than all of the world’s thousands of embryonic doctors and scientists combined---and that will still be true a decade from now!”This was the closing quote in RSCI’s May 27 press release announcing the appointments of Dr. Roberto Fernandez-Vina as Chairman of the Institute’s Science Advisory Board and Dr. Shimon Slavin as Deputy Chairman. No other institution and no commercial company has the credentials of RSCI’s scientists all in one place. Five men, all having a world-first in stem cells to his credit. To read the full article: http://repairstemcells.org/Resources/Press-Releases/2009-RSCI-Science-Advisory-Board.aspx FINAL NOTEINTRODUCTION
BY DON MARGOLIS I first discovered The Commonwealth Fund in 2006. Like most Americans, I was brainwashed to believe that our medical system was number one, yet as I got deeper into medicine from 2003-06, I saw so many holes and so many cover-up lies, that I started looking for the real truth. Here is what I found. Know that what you are about to read in this Part One is the good news, though you won’t believe that when you read it. The emphases are mine. PART ONE OF FOUR The Commonwealth Fund Why Not the Best? Results from a National
Scorecard on U.S. Health System Performance September
20, 2006 | Volume 34 Authors:
The Commonwealth Fund Commission on a High Performance Health System Scorecard Overview Created
by the Commonwealth Fund Commission on a High Performance Health System, the
National Scorecard on U.S. Health System Performance is the first-ever
comprehensive means of measuring and monitoring health care outcomes,
quality, access, efficiency, and equity in one report. Its findings indicate that America's health system falls far short of
what is attainable, especially given the resources the nation invests.
Across 37 indicators of performance, the U.S. achieves an overall score of 66
out of a possible 100 when comparing actual national performance to
achievable benchmarks. Scores on
efficiency are particularly low. This report explains how the Scorecard
works, describes results for each domain of performance, and discusses
implications for policies to improve quality, access, and cost performance. These
findings are also discussed in a Health Affairs Web Exclusive. Executive Summary Once
upon a time, it was taken as an article of faith among most Americans that
the U.S. health care system was simply the best in the world. Yet growing
evidence indicates the system falls short given the high level of resources
committed to health care. Although
national health spending is significantly higher than the average rate of
other industrialized countries, the U.S. is the only industrialized country
that fails to guarantee universal health insurance and coverage is
deteriorating, leaving millions without affordable access to preventive and
essential health care. Quality of care is highly variable and delivered
by a system that is too often poorly coordinated, driving up costs, and
putting patients at risk. With rising costs straining family, business, and
public budgets, access deteriorating and variable quality, improving health
care performance is a matter of national urgency. The
Commonwealth Fund Commission on a High Performance Health System has
developed a National Scorecard on U.S. Health System Performance (see the
table below for scores on 37 key indicators). The Scorecard assesses how well
the U.S. health system is performing as a whole relative to what is
achievable. It provides benchmarks for the nation and a mechanism for
monitoring change over time across core health care system goals of health
outcomes, quality, access, efficiency, and equity. Scores
come from ratios that compare the U.S. national average performance to
benchmarks, which represent top performance. If performance in the U.S. was
uniform for each of the health system goals, and if, in those instances in
which U.S. performance can be compared with other countries, we were
consistently at the top, the average score for the U.S. would be 100. But,
the U.S. as a whole scores an average of 66. Several different measures or
indicators were examined for each of the goal areas and dimensions of health
system performance. There are wide gaps between national average rates and
benchmarks in each of the dimensions of the Scorecard, with U. S. average
scores ranging from 51 to 71. By
showing the gaps between national performance and benchmarks that have been
achieved, the Scorecard offers performance targets for improvement. And it
provides a foundation for the development of public and private policy
action, and a yardstick against which to measure the success of new policies. Scorecard Highlights and Leading Indicators The
table summarizes U.S. average rates on 37 indicators, their benchmark
comparison rates—typically those achieved by the top 10 percent of countries,
states, health plans, hospitals, or other providers—and the U.S. average
score, calculated as the ratio between U.S. performance and benchmark rate.
In just a few instances the benchmarks represent targets, rather than
achieved top performance. The sources of the benchmarks are shown in the
table. Some
major findings include: Long, Healthy, and Productive
Lives: Total Average Score 69 * The
U.S. is one-third worse than the best country on mortality from
conditions "amenable to health care"—that is, deaths that could
have been prevented with timely and effective care. Its infant mortality rate is 7.0 deaths per 1,000 live births,
compared with 2.7 in the top three countries. The U.S. average adult
disability rate is one-fourth worse than the best five U.S. states, as is the
rate of children missing 11 or more days of school because of illness or
injury. Quality: Total Average Score 71 * Despite documented benefits of timely
preventive care, barely half of adults
(49%) received preventive and screening tests according to guidelines for
their age and sex. * The current gap between national
average rates of diabetes and blood pressure control and rates achieved by
the top 10 percent of health plans translates into an estimated 20,000 to 40,000 preventable deaths
and $1 billion to $2 billion in avoidable medical costs. * Only
half of patients with congestive heart failure receive written discharge
instructions regarding care following their hospitalization. * Nursing home hospital admission and
readmission rates in the bottom 10 percent of states are two times higher
than in the top 10 percent of states. Access: Total Average Score 67 * In 2003, one-third (35%) of adults
under 65 (61 million) were either underinsured or were uninsured at some time
during the year. * One-third (34%) of all adults under 65
have problems paying their medical bills or have medical debt they are paying
off over time. And premiums are increasingly stretching median household
incomes. Efficiency: Total Average Score 51 * National preventable hospital
admissions for patients with diabetes, congestive heart failure, and asthma
(ambulatory care sensitive conditions) were twice the level achieved by the
top states. * Hospital 30-day readmission rates for
Medicare patients ranged from 14 percent to 22 percent across regions.
Bringing readmission rates down to the levels achieved by the top performing
regions would save Medicare $1.9 billion annually. * Annual Medicare costs of care average $32,000
for patients with congestive heart failure, diabetes, and chronic lung
disease, with a twofold spread in costs across geographic regions. * As
a share of total health expenditures, U.S. insurance administrative costs
were more than three times the rates of countries with the most integrated
insurance systems. Ed note: this is because the
insurance companies take out 25% of your premiums as profits…dm * The
U.S. lags well behind other nations in use of electronic medical records:
17 percent of U.S doctors compared
with 80 percent in the top three countries. Equity: Total Average Score: 71 * On multiple indicators across quality
of care and access to care, there is a wide gap between low-income or
uninsured populations and those with higher incomes and insurance. On
average, low-income and uninsured rates would need to improve by one-third to
close the gap. * On average, it would require a 20
percent decrease in Hispanic risk rates to reach benchmark white rates on key
indicators of quality, access, and efficiency. Hispanics are at particularly
high risk of being uninsured, lacking a regular source of primary care, and
not receiving essential preventive care. * Overall, it would require a 24 percent
or greater improvement in African American mortality, quality, access, and
efficiency indicators to approach benchmark white rates. Blacks are much more likely to die at birth or from chronic
conditions such as heart disease and diabetes. Blacks also have significantly
lower rates of cancer survival. Ed note: NOT because they are black, but because
they are poor….dm Despite
the fact that the “US Health Expenditures as a % of their GDP” is almost the
highest in the world (there is only one that spends more), we have all of the
above problems with our health care system and even the World Health
Organization (WHO) ranks the US:
The system
is not working. Link:
http://repairstemcell.wordpress.com/2009/03/25/the-us-is-1-another-stem-cell-first-for-the-us/ LOOK FOR PART TWO IN JUNE INTRODUCING THE FIRST DVD IN THE WORLD TO TELL THE WHOLE TRUTH ABOUT STEM CELLS.ON JUNE
15, 2009, THE REPAIR STEM CELL INSTITUTE WILL RELEASE THE FIRST IN A SERIES
OF STEM CELL DVDs, A SERIES THAT WILL MAKE IT EASY FOR THE LAYMAN TO KNOW FAR
MORE ABOUT STEM CELLS THAN 95% OF THE MEDICAL DOCTORS IN THE WORLD. American
doctors have been so horribly misinformed about stem cells by those who run
the “Business of Medicine” that there is little chance they will ever know
the whole truth. Why? Because
virtually all stem cell articles printed in North America, and most articles
in Europe from 2004 through 2008, have been lie-filled efforts to keep
profitable patients away from stem cells that could reduce the $2 billion
dollar WEEKLY profits of the “Business of Medicine” in North America alone. NO CURES ALLOWED The
multi-billion dollar campaign has brainwashed us to “Ask Your Doctor” and is
working well. Those doctors who know
nothing are only too happy to push the pharmaceutical industry’s agenda and
bolster the party-line to their trusting and unsuspecting patients. So patients are led to NOT get better, but
to continue to suffer even more years with toxic pills and useless therapies
to treat diseases that are incurable ONLY in a medical system that allows no
cures! In fact, if you started to
collect your Social Security this year, you were only six years old when
American Medical Science conquered its last disease. Since then, not a single additional disease
has been cured! DEATH ROW “…since
few people can afford to travel outside the country for adult stem cell
treatments, ESC-crazed America, the Bangladesh of stem cells, with its focus
on “treatment useless” research, and 4-8 years behind the rest of the world
on available adult stem cell treatments, has become
exactly that, a death row prison cell for those suffering from so-called
untreatable diseases.” http://repairstemcell.wordpress.com/2009/03/21/2793/ Today, no American
scientist or doctor dares to cure anything that will reduce those profits of
his Lords & Masters. But YOU can
dare! This issue’s “Final Note”
article above is the first of four parts describing exactly why your
medical system is the worst in the developed world. “Why Not the Best?” was written by the only
organization in the world capable of judging medical systems accurately, The
Commonwealth Fund. Once you
understand how ineffective the US medical system is, you will know what you
need to do. You must defend yourself
and your loved ones from a “Death Row” system that insists you stay home,
take drug after drug and die slowly and uncomfortably, rather than
recover. IF you can both accept this
fact AND dare to seek out the best care, you will be prepared with the
knowledge of alternative options when your loved one is told “There is
nothing we can do.” The key
video (of four in the DVD) is a complete explanation of why there will never
be a disease treated with embryonic stem cells in your lifetime, despite what
the con men in California and the politicians tell you. Here are the opening two minutes of script: STEM CELLS 102
Why EMBRYONIC STEM CELLS cannot become REPAIR
STEM CELLS. 1.
Referring back to Stem Cells 101, we learned how
Adult Stem Cells, which we prefer to call REPAIR STEM CELLS, when sent to a
part of the body that needs help, stay there and duplicate themselves until
there are enough to repair a problem quickly, like in weeks. That is why we call them Repair stem
cells---that is what they do---that is what they are. 2.
Embryonic pitchmen pretend that their stem cells
hold more “promise,” saying they can become anything and Repair Stem Cells
Cannot. Nothing could possibly be
further from the truth. Knowing full well that they are not able to produce one
EMBRYONIC STEM CELL which can safely be put into a human and reduce the
symptoms of a disease, they deny the truth, thus denying YOU of treatments
that work today while you wait for their 21st century alchemy to
turn embryonic LEAD into Repair Stem Cell GOLD. 3.
Repair Stem Cells are right now being used to
successfully treat over 100 diseases. Embryonics? Zero. Nada. Rien. Nichts.
Nichevo. 4.
This video will show you why the EMBRYONIC STEM
CELLS always fail to repair. Other lessons on the DVD are Stem Cells 101 condensed into 16 minutes. Dr. Carlos Lima & Christopher Reeve The Embryonic “Promise.” STEM CELLS 102 can be purchased for $19.34 + S&H starting June 15 on this website (RSCI) and others. |
||
|
NEXT MONTH More Real Names of Real People in recovery. Part 2 of “Why not the Best?” Introducing the finest children’s book on
stem cells. And more |
||
|
Contact USA Direct Line: |
Don Margolis, Chairman |
|
|
www.repairstemcells.com |
www.donrmargolis.com |
|
|
LEGAL DISCLAIMER This Newsletter is for
educational purposes only and not to be taken as medical advice. |
||
